This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Neovent - Salmeterol

Kent Pharmaceuticals

Description

Long-acting selective beta2 agonist.

Reversible airways obstruction in patients requiring long-term regular bronchodilator therapy
Nocturnal asthma in patients requiring long-term regular bronchodilator therapy
Prevention of exercise-induced bronchospasm in patients requiring long-term regular bronchodilator therapy
Chronic asthma only in patients who regularly use an inhaled corticosteroid (not for immediate relief of acute asthma)
By inhalation of aerosol, or by inhalation of powder
• Child 5–11 years: 50 mcg, twice daily.
• Over 12 years: by inhalation, 50 mcg twice daily. Up to 100 mcg twice daily for more severe airway obstruction.

For COPD by inhalation of aerosol, or by inhalation of powder
• Adult: 50 mcg (2 puffs or 1 blister), twice daily.

Indications

For the management of reversible airways obstruction (including nocturnal asthma and the prevention of exercise-induced bronchospasm) in patients requiring long-term regular bronchodilator therapy, and COPD.

Contraindications

Not advised during pregnancy and breast feeding.

Preparations Available

Pressurised inhalation

Sizes Available

Pressurised inhalation
Neovent 25 mcg/dose, 120 doses, CFC free

More on: Bronchodilators , Long-acting selective beta2: agonists